Chemical proteomics decrypts the kinases that shape the dynamic human phosphoproteome
Authors:
- Florian P. BayerFBFlorian P. Bayer
- Julian MüllerJMJulian Müller
- Nicole KabellaNKNicole Kabella
- Miriam AbeleMAMiriam Abele
- Yun-Chien ChangYCYun-Chien Chang
- Leonardo Daniel Estrada DuenasLDLeonardo Daniel Estrada Duenas
- Cecilia JensenCJCecilia Jensen
- Firas HamoodFHFiras Hamood
- Chien-Yun LeeCLChien-Yun Lee
- Annika SchneiderASAnnika Schneider
- Matthew TheMTMatthew The
- Bernhard KusterBKBernhard Kuster
Preprint
Abstract
Mass-spectrometry-based phosphoproteomics enables the analysis of thousands of protein phosphorylation events across the human proteome. However, there is a lack of scalable, hypothesis-free, and statistically sound approaches for discovering, evaluating, and falsifying kinase::substrate relationships (KSRs). Here, we developed a new concept termed potency-coherence analysis. By measuring and integrating 17 million peptidoform-specific dose-response curves for 133 kinase inhibitors with known targets and affinities, we could critically re-evaluate published KSRs and discover thousands of potency-coherent and motif-plausible new KSRs for 96 human kinases. Application of these high-confidence KSRs enabled the estimation of kinase and signaling pathway activities in cancer patient biopsies. This unified and extendable framework has been implemented in ProteomicsDB to aid researchers in understanding the human phosphoproteome in health and disease.Keywords
Funding Information
- European Research Council (TOPAS833710)
- European Union (EPIC-XS823839)
This publication has 69 references indexed in Scilit:
- Probing cancer with small-molecule tools—Progress and challengesCancer Cell, 2025
- Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomicsCell Reports, 2024
- Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancersAnnals of Oncology, 2022
- Defining a Cancer Dependency MapCell, 2017
- Data Conversion with ProteoWizard msConvert2017
- Fast and Accurate Protein False Discovery Rates on Large-Scale Proteomics Data Sets with Percolator 3.0Journal of the American Society for Mass Spectrometry, 2016
- Evolution and functional cross‐talk of protein post‐translational modificationsMolecular Systems Biology, 2013
- The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling NetworksCell, 2006